Analytical Data
-
Gene name
CLTB
- Application
-
Alternative Names
Lcb
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P09497
-
Expression Region
Met1~Arg229
-
Molecular Weight
39kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CLTB, or Clathrin-Like Protein B, is a member of the clathrin-related protein family that plays a critical role in various biological processes, including endocytosis and intracellular trafficking. Its research background is rooted in understanding cellular transport mechanisms that are essential for maintaining cellular homeostasis and responding to environmental stimuli. Studies have shown that CLTB is involved in the formation of clathrin-coated vesicles, which facilitate the internalization of receptors and other membrane proteins. The interest in CLTB has grown, particularly in its potential implications for diseases such as cancer, neurodegenerative disorders, and viral infections, where endocytic pathways are often disrupted. By reconstituting CLTB as a recombinant protein, researchers aim to elucidate its structural and functional properties, enabling the investigation of its role in cellular processes. The study of CLTB via recombinant techniques allows for detailed biochemical analyses and the exploration of its interactions with other cellular components, paving the way for therapeutic advancements. Overall, the research on CLTB and its recombinant forms contributes significantly to the understanding of fundamental cellular mechanisms and their relevance to human health.
